Surgical program building in advanced ovarian cancer: European perspective

Gynecologic Oncology

Volumn 114, Issue 2 SUPPL., 2009, Pages

  Verleye, L ^a   Ottevanger, P B ^b   Vergote, I ^c  

^a EORTC DATA CENTER   (Belgium)

^b RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^c UNIVERSITY HOSPITALS LEUVEN   (Belgium)

Author keywords

Ovarian cancer; Program building; Surgery; Training

Indexed keywords

ANTIBIOTIC AGENT; ANTINEOPLASTIC AGENT; PLATINUM DERIVATIVE;

ADVANCED CANCER; ANESTHESIST; ARTICLE; CANCER CENTER; CANCER PATIENT; CANCER RADIOTHERAPY; CANCER SURGERY; CYTOREDUCTIVE SURGERY; DIETITIAN; HEALTH CARE DELIVERY; HEALTH CARE PERSONNEL; HEALTH CARE PLANNING; HEALTH CARE QUALITY; HUMAN; NURSE; OVARY CANCER; PALLIATIVE THERAPY; PATHOLOGIST; PATIENT CARE; PHYSIOTHERAPIST; PRIORITY JOURNAL; PROGNOSIS; SKILL; SURGEON; TEAMWORK;

CANCER CARE FACILITIES; FEMALE; GYNECOLOGIC SURGICAL PROCEDURES; HUMANS; OVARIAN NEOPLASMS; PROGRAM DEVELOPMENT;

EID: 67649382934     PISSN: 00908258     EISSN: 10956859     Source Type: Journal    
DOI: 10.1016/j.ygyno.2008.11.019     Document Type: Article

References (77)

1. Ferlay J., Autier P., Boniol M., Heanue M., Colombet M., and Boyle P. Estimates of the cancer incidence and mortality in Europe in 2006. Ann. Oncol. 18 3 (2007) 581-592
2. Albreht T., McKee M., Alexe D.M., Coleman M.P., and Martin-Moreno J.M. Making progress against cancer in Europe in 2008. Eur. J. Cancer 44 10 (2008) 1451-1456
3. Gouveia J., Coleman M.P., Haward R., Zanetti R., Hakama M., Borras J.M., et al. Improving cancer control in the European Union: conclusions from the Lisbon round-table under the Portuguese EU Presidency, 2007. Eur. J. Cancer 44 10 (2008) 1457-1462
4. Coebergh J.W., and Albreht T. Should the EU also wage war against cancer? And if so, how? Foreword and afterthoughts to this special issue on cancer control at the European level. Eur. J. Cancer 44 10 (2008) 1341-1344
5. Bray F., Loos A.H., Tognazzo S., and La V.C. Ovarian cancer in Europe: cross-sectional trends in incidence and mortality in 28 countries, 1953-2000. Int. J. Cancer 113 6 (2005) 977-990
6. Boyle P., and Ferlay J. Cancer incidence and mortality in Europe, 2004. Ann. Oncol. 16 3 (2005) 481-488
7. Colombo N., van Gorp T., Parma G., Amant F., Gatta G., Sessa C., et al. Ovarian cancer. Crit. Rev. Oncol. Hematol. 60 2 (2006) 159-179
8. Rosenthal A.N., Menon U., and Jacobs I.J. Screening for ovarian cancer. Clin. Obstet. Gynecol. 49 3 (2006) 433-447
9. Hacker N.F. Controversial aspects of cytoreductive surgery in epithelial ovarian cancer. Bailliere's Clin. Obstet. Gynaecol. 3 1 (1989) 49-57
10. Engel J., Eckel R., Schubert-Fritschle G., Kerr J., Kuhn W., Diebold J., et al. Moderate progress for ovarian cancer in the last 20 years: prolongation of survival, but no improvement in the cure rate. Eur. J. Cancer 38 18 (2002) 2435-2445
11. Bristow R.E., Tomacruz R.S., Armstrong D.K., Trimble E.L., and Montz F.J. Survival effect of maximal cytoreductive surgery for advanced ovarian carcinoma during the platinum era: a meta-analysis. J. Clin. Oncol. 20 5 (2002) 1248-1259
12. Trope C., and Kaern J. Primary surgery for ovarian cancer. Eur. J. Surg. Oncol. 32 8 (2006) 844-852
13. Giede K.C., Kieser K., Dodge J., and Rosen B. Who should operate on patients with ovarian cancer? An evidence-based review. Gynecol. Oncol. 99 2 (2005) 447-461
14. Vernooij F., Heintz P., Witteveen E., and van der Graaf Y. The outcomes of ovarian cancer treatment are better when provided by gynecologic oncologists and in specialized hospitals: a systematic review. Gynecol. Oncol. 105 3 (2007) 801-812
15. Vernooij F., Heintz A.P., Witteveen P.O., van der Heiden-van der Loo, Coebergh J.W., and van der Graaf Y. Specialized care and survival of ovarian cancer patients in The Netherlands: nationwide cohort study. J. Natl. Cancer Inst. 100 6 (2008) 399-406
16. Munstedt K., von Georgi R., Misselwitz B., Zygmunt M., Stillger R., and Kunzel W. Centralizing surgery for gynecologic oncology-a strategy assuring better quality treatment?. Gynecol. Oncol. 89 1 (2003) 4-8
17. Tingulstad S., Skjeldestad F.E., and Hagen B. The effect of centralization of primary surgery on survival in ovarian cancer patients. Obstet. Gynecol. 102 3 (2003) 499-505
18. Gagliardi A.R., Fung M.F., Langer B., Stern H., and Brown A.D. Development of ovarian cancer surgery quality indicators using a modified Delphi approach. Gynecol. Oncol. 97 2 (2005) 446-456
19. World Health Organization. Cancer control. Knowledge into action. WHO guide for effective programmes. Planning. Geneva: WHO press; 2006.
20. World Health Organization. Cancer Control. Knowledge into action. WHO guide for effective programmes. Diagnosis and Treatment. Geneva: WHO press; 2006.
21. Munstedt K., von Georgi R., Zygmunt M., Misselwitz B., Stillger R., and Kunzel W. Shortcomings and deficits in surgical treatment of gynecological cancers: a German problem only?. Gynecol. Oncol. 86 3 (2002) 337-343
22. Junor E.J., Hole D.J., McNulty L., Mason M., and Young J. Specialist gynaecologists and survival outcome in ovarian cancer: a Scottish national study of 1866 patients. Br. J. Obstet. Gynaecol. 106 11 (1999) 1130-1136
23. Soegaard Andersen E., Knudsen A., Svarrer T., Lund B., Nielsen K., Grove A., et al. The results of treatment of epithelial ovarian cancer after centralisation of primary surgery. Results from North Jutland, Denmark. Gynecol. Oncol. 99 3 (2005) 552-556
24. Junor E.J., Hole D.J., and Gillis C.R. Management of ovarian cancer: referral to a multidisciplinary team matters. Br. J. Cancer 70 2 (1994) 363-370
25. Wolfe C.D., Tilling K., and Raju K.S. Management and survival of ovarian cancer patients in south east England. Eur. J. Cancer 33 11 (1997) 1835-1840
26. Sengupta P.S., Jayson G.C., Slade R.J., Eardley A., and Radford J.A. An audit of primary surgical treatment for women with ovarian cancer referred to a cancer centre. Br. J. Cancer 80 3-4 (1999) 444-447
27. Shylasree T.S., Howells R.E., Lim K., Jones P.W., Fiander A., Adams M., et al. Survival in ovarian cancer in Wales: prior to introduction of all Wales guidelines. Int. J. Gynecol. Cancer 16 5 (2006) 1770-1776
28. Akeson M., Zetterqvist B.M., Holmberg E., and Horvath G. Improved survival with clinical guidelines? Evaluation of a quality register linked to clinical guidelines for ovarian cancer in the western health care region in Sweden between 1 September 1993 and 1 June 1998. Acta Obstet. Gynecol. Scand. 84 11 (2005) 1113-1118
29. Engelen M.J., van der Zee A.G., de Vries E.G., and Willemse P.H. Debulking surgery for ovarian epithelial cancer performed by a gynaecological oncologist improved survival compared with less specialised surgeons. Cancer Treat. Rev. 32 4 (2006) 320-323
30. du Bois A., Rochon J., Lamparter C., and Pfisterer J. Pattern of care and impact of participation in clinical studies on the outcome in ovarian cancer. Int. J. Gynecol. Cancer 15 2 (2005) 183-191
31. Bailey J., Murdoch J., Anderson R., Weeks J., and Foy C. Stage III and IV ovarian cancer in the South West of England: five-year outcome analysis for cases treated in 1998. Int. J. Gynecol. Cancer 16 Suppl 1 (2006) 25-29
32. Oberaigner W., and Stuhlinger W. Influence of department volume on cancer survival for gynaecological cancers-a population-based study in Tyrol, Austria. Gynecol. Oncol. 103 2 (2006) 527-534
33. Mainz J. Defining and classifying clinical indicators for quality improvement. Int. J. Qual. Health Care 15 6 (2003) 523-530
34. Caldwell D.F., Chatman J., O'Reilly III C.A., Ormiston M., and Lapiz M. Implementing strategic change in a health care system: the importance of leadership and change readiness. Health Care Manage Rev. 33 2 (2008) 124-133
35. Silber J.H., Rosenbaum P.R., Polsky D., Ross R.N., Even-Shoshan O., Schwartz J.S., et al. Does ovarian cancer treatment and survival differ by the specialty providing chemotherapy?. J. Clin. Oncol. 25 10 (2007) 1169-1175
36. van Hester H. Behandeling eierstokkanker kan beter. (http://www.nrc.nl/wetenschap/article1883834.ece/Behandeling_eierstokkanker_kan_beter).
37. NVOG. Nota gynaecoloog met oncologie als aandachtsgebied. (http://www.nvog-documenten.nl/index.php?pagina=/richtlijn/item/pagina.phpandrichtlijn_id=768).
38. Royal College of Obstetricians and Gynaecologists. Introduction to subspecialty training in Obstetrics and Gynaecology. (http://www.rcog.org.uk/index.asp?PageID=1954).
39. ESGO-EBCOG. ESGO-EBCOG Subspecialty Training Programme in Gynaecolgocial Oncology. (http://www.esgo.org/pdf/1-ESGO-EBCOG_Subspecialty_Training_Programme_inGO.pdf).
40. ESGO-EBCOG. ESGO-EBCO Logbook for Trainees in Gynaecological Oncology. (http://www.esgo.org/pdf/6-ESGO-EBCOG_Logbook_for_fellows.pdf).
41. Eisenkop S.M., and Spirtos N.M. What are the current surgical objectives, strategies, and technical capabilities of gynecologic oncologists treating advanced epithelial ovarian cancer?. Gynecol. Oncol. 82 3 (2001) 489-497
42. Devolder K., Amant F., Neven P., van Gorp T., Leunen K., and Vergote I. Role of diaphragmatic surgery in 69 patients with ovarian carcinoma. Int. J. Gynecol. Cancer 18 2 (2008) 363-368
43. van Dam P.A., Tjalma W., Weyler J., van Oosterom A.T., and Buytaert P. Ultraradical debulking of epithelial ovarian cancer with the ultrasonic surgical aspirator: a prospective randomized trial. Am. J. Obstet. Gynecol. 174 3 (1996) 943-950
44. NHS Institute for Innovation and Improvement. NHS Leadership Qualities Framework. (http://www.nhsleadershipqualities.nhs.uk/portals/0/the_framework.pdf).
45. World Alliance for Patient Safety. WHO Guidelines for Safe Surgery. first ed (2008), WHO press, Geneva
46. Arain M.R., and Buggy D.J. Anaesthesia for cancer patients. Curr. Opin. Anaesthesiol. 20 3 (2007) 247-253
47. Diaz-Montes T.P., Zahurak M.L., and Bristow R.E. Predictors of extended intensive care unit resource utilization following surgery for ovarian cancer. Gynecol. Oncol. 107 3 (2007) 464-468
48. Selman A.E., Niemann T.H., Fowler J.M., and Copeland L.J. Quality assurance of second opinion pathology in gynecologic oncology. Obstet. Gynecol. 94 2 (1999) 302-306
49. Chan Y.M., Cheung A.N., Cheng D.K., Ng T.Y., Ngan H.Y., and Wong L.C. Pathology slide review in gynecologic oncology: routine or selective?. Gynecol. Oncol. 75 2 (1999) 267-271
50. Kronz J.D., Westra W.H., and Epstein J.I. Mandatory second opinion surgical pathology at a large referral hospital. Cancer 86 11 (1999) 2426-2435
51. Khalifa M.A., Dodge J., Covens A., Osborne R., and Ackerman I. Slide review in gynecologic oncology ensures completeness of reporting and diagnostic accuracy. Gynecol. Oncol. 90 2 (2003) 425-430
52. Lanceley A., Savage J., Menon U., and Jacobs I. Influences on multidisciplinary team decision-making. Int. J. Gynecol. Cancer 18 2 (2008) 215-222
53. World Health Organization. Team Building (2007), WHO press, Geneva
54. World Health Organization. Strategies to improve and strengthen cancer control programmes in Europe. Report of a WHO consultation, Geneva 25-28,2003. Geneva: WHO press; 2003.
55. Kitchener H.C. Clinical practice guidelines: loss of clinical freedom or a coming of age?. Int. J. Gynecol. Cancer 12 4 (2002) 332-336
56. Benedet J.L., Bender H., Jones III H., Ngan H.Y., and Pecorelli S. FIGO staging classifications and clinical practice guidelines in the management of gynecologic cancers. FIGO Committee on Gynecologic Oncology. Int. J. Gynaecol. Obstet. 70 2 (2000) 209-262
57. Obeidat B.R., Amarin Z.O., Latimer J.A., and Crawford R.A. Risk of malignancy index in the preoperative evaluation of pelvic masses. Int. J. Gynaecol. Obstet. 85 3 (2004) 255-258
58. Bailey J., Tailor A., Naik R., Lopes A., Godfrey K., Hatem H.M., et al. Risk of malignancy index for referral of ovarian cancer cases to a tertiary center: does it identify the correct cases?. Int. J. Gynecol. Cancer 16 Suppl 1 (2006) 30-34
59. Jacobs I., Oram D., Fairbanks J., Turner J., Frost C., and Grudzinskas J.G. A risk of malignancy index incorporating CA 125, ultrasound and menopausal status for the accurate preoperative diagnosis of ovarian cancer. Br. J. Obstet. Gynaecol. 97 10 (1990) 922-929
60. Davies A.P., Jacobs I., Woolas R., Fish A., and Oram D. The adnexal mass: benign or malignant? Evaluation of a risk of malignancy index. Br. J. Obstet. Gynaecol. 100 10 (1993) 927-931
61. Ma S., Shen K., and Lang J. A risk of malignancy index in preoperative diagnosis of ovarian cancer. Chin. Med. J. (Engl) 116 3 (2003) 396-399
62. Asif N., Sattar A., Dawood M.M., Rafi T., Aamir M., and Anwar M. Pre-operative evaluation of ovarian mass: risk of malignancy index. J. Coll. Physicians Surg. Pak. 14 3 (2004) 128-131
63. Yazbek J., Aslam N., Tailor A., Hillaby K., Raju K.S., and Jurkovic D. A comparative study of the risk of malignancy index and the ovarian crescent sign for the diagnosis of invasive ovarian cancer. Ultrasound Obstet. Gynecol. 28 3 (2006) 320-324
64. Ulusoy S., Akbayir O., Numanoglu C., Ulusoy N., Odabas E., and Gulkilik A. The risk of malignancy index in discrimination of adnexal masses. Int. J. Gynaecol. Obstet. 96 3 (2007) 186-191
65. Timmerman D., Testa A.C., Bourne T., Ameye L., Jurkovic D., Van H.C., et al. Simple ultrasound-based rules for the diagnosis of ovarian cancer. Ultrasound Obstet. Gynecol. 31 6 (2008) 681-690
66. Verleye L, Ottevanger PB, van der Graaf W, Reed NS, Vergote I.EORTC -GCG process quality indicators for ovarian cancer surgery. Eur J Cancer. doi:10.1016/j.ejca.2008.09.031.
67. World Alliance for Patient Safety. WHO draft guidelines for adverse event reporting and learning systems. From information to action. Geneva: WHO press; 2005.
68. European Union of Medical Specialists. Charter on Quality Assurance in Medical Specialist Practice in the European Union. (http://admin.uems.net/uploadedfiles/174.pdf).
69. Berrino F., De A.R., Sant M., Rosso S., Bielska-Lasota M., Coebergh J.W., et al. Survival for eight major cancers and all cancers combined for European adults diagnosed in 1995-99: results of the EUROCARE-4 study. Lancet Oncol. 8 9 (2007) 773-783
70. Verdecchia A., Francisci S., Brenner H., Gatta G., Micheli A., Mangone L., et al. Recent cancer survival in Europe: a 2000-02 period analysis of EUROCARE-4 data. Lancet Oncol. 8 9 (2007) 784-796 Sep
71. Royal College of Obstetricians and Gynaecologists. Clinical Standards. Advice on planning the service in Obstetrics and Gynaecology. (http://www.rcog.org.uk/resources/public/pdf/WP_Clinical_Standards.pdf).
72. Jolly K., Parry J., Rouse A., and Stevens A. Volumes of cancer surgery for breast, colorectal and ovarian cancer 1992-97: is there evidence of increasing sub-specialization by surgeons?. Br. J. Cancer 84 10 (2001) 1308-1313
73. Royal College of Obstetricians and Gynaecologists. Gynaecological Oncology. (http://www.rcog.org.uk/resources/public/pdf/tp_17_gynaecological_oncology.pdf).
74. Vergote I., De Oliveira C., and Dargent D. How to organize gynecologic oncology in the future: results of an international questionnaire. Int. J. Gynecol. Cancer 7 5 (1997) 368-375
75. Benedetti-Panici P., and Angioli R. Gynecologic Oncology specialty: progressing towards recognition in Europe. Crit. Rev. Oncol. Hematol. 48 3 (2003) 249-250
76. Ministerieel besluit tot vaststelling van de bijzondere criteria voor de erkenning van geneesheren-specialisten, houders van de bijzondere beroepstitel in de medische oncologie en van de bijzondere beroepsbekwaamheid in de oncologie evenals van stagemeesters en stagediensten. (www.staatsblad.be).
77. Paulsen T., Kjaerheim K., Kaern J., Tretli S., and Trope C. Improved short-term survival for advanced ovarian, tubal, and peritoneal cancer patients operated at teaching hospitals. Int. J. Gynecol. Cancer 16 Suppl. 1 (2006) 11-17